4.5 Review

Heterogeneity and functions of the 13 IFN-a subtypes - lucky for some?

Related references

Note: Only part of the references are listed.
Article Cell Biology

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNa and B cell subsets

Hannah F. Bradford et al.

Summary: Systemic lupus erythematosus (SLE) patients often exhibit increased expression of type I interferon (IFN)-regulated genes. In our study of 501 SLE patients, we found that 73 (14%) had autoantibodies against IFN-alpha (anti-IFN-Abs). The presence of neutralizing anti-IFN-Abs in 4.2% of patients correlated with low IFN-alpha protein levels, inhibition of IFN-I downstream gene signatures, and inactive disease score. These neutralizing anti-IFN-Abs were found to play a role in controlling SLE pathogenesis, specifically in regulating B cell populations.

CELL REPORTS MEDICINE (2023)

Review Biotechnology & Applied Microbiology

Emerging principles of cytokine pharmacology and therapeutics

Robert A. Saxton et al.

Summary: The use of cytokines for therapeutic purposes has been restricted due to their pleiotropic activity. However, recent insights from structural biology, protein engineering, and receptor pharmacology have provided strategies to overcome cytokine pleiotropy and develop improved cytokine-based therapeutics.

NATURE REVIEWS DRUG DISCOVERY (2023)

Article Immunology

Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019

Elana R. Shaw et al.

Summary: Levels and activity of anti-type 1 interferon autoantibodies peak during acute coronavirus disease 2019 and decrease thereafter. Despite lower levels, most patients in convalescence still have some ability to neutralize type 1 interferon. Identifying these autoantibodies in healthy individuals before critical viral disease develops may be challenging.

CLINICAL INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection

Jonas Schuhenn et al.

Summary: This study found that different subtypes of IFN-alpha have varying antiviral activity against SARS-CoV-2, with IFN-alpha 5 showing the highest efficacy. Combination treatment with the broad antiviral drug remdesivir enhanced the antiviral effect. These findings are important for understanding the mechanism of IFN-I-mediated antiviral response and developing treatments for COVID-19.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jeremy Manry et al.

Summary: This study investigates the impact of autoimmunity on COVID-19-related deaths and finds that individuals carrying autoantibodies neutralizing type I interferons are at higher risk of death, with the risk decreasing with age.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Rheumatology

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

Alexis Mathian et al.

Summary: This study finds that neutralizing and non-neutralizing autoantibodies against type-I interferons (IFNs-I) are present in patients with systemic lupus erythematosus (SLE). Neutralizing anti-IFN-alpha antibodies are associated with reduced IFN-alpha levels and a decreased likelihood of developing active disease, but they increase the risk of herpes zoster and severe COVID-19 pneumonia. Severe COVID-19 pneumonia in SLE patients is mainly associated with combined neutralization of different IFNs-I.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Immunology

Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals

Zehra Karakoese et al.

Summary: Specific type I IFN subtypes (IFNα2, IFNα14, and IFNβ) exert distinct potencies in stimulating T and NK cell responses during HIV-1 infection. IFNα14 and IFNβ significantly increase the frequencies of degranulating gut-derived CD4(+) T cells and blood-derived T and NK cells, while reducing the frequencies of IFNγ-expressing T cells. Moreover, subtype-specific phosphorylation of downstream molecules and differences in STAT5 phosphorylation were observed in healthy peripheral blood mononuclear cells (PBMCs) and PBMCs of HIV-infected individuals.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

IFNα subtype-specific susceptibility of HBV in the course of chronic infection

Xiaohong Xie et al.

Summary: Chronic hepatitis B virus (HBV) infection is difficult to cure, and interferon alpha (IFN-alpha) therapy is an important method for clinical treatment. Different subtypes of IFN-alpha show variations in antiviral and immunomodulatory effects, and all subtypes are strongly expressed in the spleen during persistent HBV infection in mice.

FRONTIERS IN IMMUNOLOGY (2022)

Article Gastroenterology & Hepatology

Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ Signaling

Jieliang Chen et al.

Summary: The study identified IFN-alpha 14 as the most effective subtype in suppressing HBV replication, with significantly lower concentration values compared to conventional IFN-alpha 2. IFN-alpha 14 triggered a strong antiviral response through IFN-alpha and IFN-gamma signaling crosstalk, revealing mechanisms for potent HBV suppression. The findings deepen the understanding of the diverse activities of IFN-alpha subtypes and the synergistic effects of IFN-alpha and IFN-gamma signaling, potentially leading to improved HBV therapy strategies.

HEPATOLOGY (2021)

Review Immunology

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes

Megen C. Wittling et al.

Summary: Type I interferons (IFN-I) were first discovered as antiviral factors, but they also modulate immunity and suppress cancer cell proliferation. There are 16 different IFN-I gene products, and investigating their shared and unique aspects is important for understanding their roles.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine

Paul Bastard et al.

Summary: In rare cases, yellow fever virus (YFV) live attenuated vaccine can cause life-threatening disease, particularly in patients with no history of severe viral illness. Some patients with auto-Abs against multiple type I interferons and autosomal recessive IFNAR1 or IFNAR2 deficiency were found to be at risk of developing severe complications after YFV vaccination. Testing for these predispositions could be considered for healthy individuals before YFV vaccination.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Differential levels of IFNα subtypes in autoimmunity and viral infection

Vincent Bondet et al.

Summary: The study developed a highly sensitive digital ELISA for IFN alpha 2 subtype and identified different IFN alpha protein responses in viral infection and autoimmune patients. A small subset of autoimmune patients showed high IFN alpha 2 protein measurements but low pan-IFN alpha measurements, which were partly explained by the presence of anti-IFN alpha auto-antibodies. The study highlights the importance of ultrasensitive assays and multiple phenotypic readouts in translational and clinical studies.

CYTOKINE (2021)

Review Immunology

Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway

Isabelle Meyts et al.

Summary: The study reveals a greater redundancy of human type I interferons for protective immunity to viruses in natural conditions than initially anticipated, while mouse type I interferons are essential for protection against a broad range of viruses in experimental settings. Various type I interferon-independent mechanisms of human cell-intrinsic immunity to viruses have yet to be discovered.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Review Pediatrics

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy

Elise M. N. Ferre et al.

Summary: APECED, also known as APS-1, is a rare monogenic autoimmune disease caused by loss-of-function mutations in the AIRE gene. Its main clinical manifestations include CMC, hypoparathyroidism, and primary adrenal insufficiency, with additional non-endocrine autoimmune manifestations possible in patients.

FRONTIERS IN PEDIATRICS (2021)

Article Immunology

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

Paul Bastard et al.

Summary: Autoantibodies neutralizing interferons are present in a significant percentage of critical COVID-19 patients, especially in older individuals, and their prevalence increases with age.

SCIENCE IMMUNOLOGY (2021)

Article Rheumatology

IFN-alpha kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study

Frederic A. Houssiau et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Article Biotechnology & Applied Microbiology

Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infection

Lei Yang et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Review Immunology

Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections

Patricio L. Acosta et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Review Immunology

The Role of Structure in the Biology of Interferon Signaling

Mark R. Walter

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription

Ekaterini Platanitis et al.

NATURE COMMUNICATIONS (2019)

Article Immunology

Detection of interferon alpha protein reveals differential levels and cellular sources in disease

Mathieu P. Rodero et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection

Yanpeng Li et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)

Article Biochemistry & Molecular Biology

AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

Steffen Meyer et al.

Review Immunology

Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview

Mathieu P. Rodero et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Virology

Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo

Kerry J. Lavender et al.

JOURNAL OF VIROLOGY (2016)

Article Biochemistry & Molecular Biology

A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity

David J. Marchant et al.

NATURE MEDICINE (2014)

Article Multidisciplinary Sciences

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

Elizabeth B. Wilson et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

John R. Teijaro et al.

SCIENCE (2013)

Article Biochemistry & Molecular Biology

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

Christoph Thomas et al.

Article Biochemistry & Molecular Biology

Binding and activity of all human alpha interferon subtypes

Thomas B. Lavoie et al.

CYTOKINE (2011)

Article Immunology

Evolutionary genetic dissection of human interferons

Jeremy Manry et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Review Biochemistry & Molecular Biology

The role of differential expression of human interferon-A genes in antiviral immunity

Pierre Genin et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2009)

Article Medicine, General & Internal

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I

E. S. Husebye et al.

JOURNAL OF INTERNAL MEDICINE (2009)

Article Virology

Enhanced anti-HCV activity of interferon alpha 17 subtype

Aurelie Dubois et al.

VIROLOGY JOURNAL (2009)

Article Rheumatology

Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C

Vincent Ho et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)

Article Biochemistry & Molecular Biology

Rigid Interferon-α Subtype Responses of Human Plasmacytoid Dendritic Cells

Richard Szubin et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)

Review Multidisciplinary Sciences

Origin and physiological roles of inflammation

Ruslan Medzhitov

NATURE (2008)

Review Biochemistry & Molecular Biology

JAK-STAT signaling: From interferons to cytokines

Christian Schindler et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Immunology

Interferons, interferon-like cytokines, and their receptors

S Pestka et al.

IMMUNOLOGICAL REVIEWS (2004)

Article Biochemical Research Methods

Differential expression of IFN-α subtypes in human PBMC:: evaluation of novel real-time PCR assays

S Löseke et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2003)